- Category
- Micro (2020-21)
- Udyam number
- UDYAM-UP-59-0005266

X-Med Royal Pharma Private Limited
About X-Med Royal Pharma Private Limited
Data last updated:
X-Med Royal Pharma Private Limited is a private limited company based in Moradabad, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 20 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2020PTC128006.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Mukhtar Hussain and Miraj Ul Nabi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 204 – A Lajpat Nagar, Moradabad, Uttar Pradesh, India – 244001.
As per the financials filed for FY 2025, the company reported a revenue of ₹57.2 Lakh, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹26,852 (net margin 0.5%) and EBITDA of ₹36,287 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years.
X-Med Royal Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-59-0005266).
Company details
Recognitions & Rankings of X-Med Royal Pharma
Contact details
X-Med Royal Pharma Private Limited's registered office is in Moradabad, Uttar Pradesh.
- Registered Address204 – A Lajpat Nagar, Moradabad, Uttar Pradesh, India – 244001
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of X-Med Royal Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of X-Med Royal Pharma Private Limited, buy the company report.
Financials of X-Med Royal Pharma Private Limited
FY 2025 filings availableX-Med Royal Pharma Private Limited reported revenue of ₹57.2 Lakh (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over three years, including 33% growth in the latest year. EBITDA rose 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹36,287 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26,852 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of X-Med Royal Pharma Private Limited, buy the company report.
Board of directors of X-Med Royal Pharma Private Limited
X-Med Royal Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukhtar Hussain | Director | 08 Oct 2020 | 6 Years 1 Months | Current |
| Miraj Ul Nabi | Director | 20 Mar 2020 | 6 Years 7 Months | Current |
| Mohammad Fareed | Director | 20 Mar 2020 | 6 Years 7 Months | Current |
| Qurresh Husain | Director | 20 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
X-Med Royal Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Science House Healthcare Private Limited | ₹57.27 Lakh (FY 2024) | 404.0% | Raipur, Chhattisgarh, India | |||
| Yrs World Trade Corporate Private Limited | ₹57.25 Lakh (FY 2016) | 784.0% | Jalandhar, Punjab, India | |||
| Dasam Kirat Dialysis Center Private Limited | ₹57.25 Lakh (FY 2024) | 2.0% | Chandigarh, India | |||
| Badgu Health Services Private Limited | ₹57.23 Lakh (FY 2019) | -12.0% | Gulbarga, Karnataka, India | |||
| Anagen Clinics Private Limited | ₹57.2 Lakh (FY 2025) | 60.0% | Mumbai, Maharashtra, India | |||
| X-Med Royal Pharma Private Limitedthis company | ₹57.2 Lakh (FY 2025) | ₹26,852 | 0.5% | 33.0% | Moradabad, Uttar Pradesh, India | |
| Vispala Technologies Private Limited | ₹57.2 Lakh (FY 2025) | -6.0% | Kolkata, West Bengal, India | |||
| Ms Bio Pharmaceuticals Private Limited | ₹57.16 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Cellpro Systems Private Limited | ₹57.15 Lakh (FY 2024) | 2716.0% | Faridabad, Haryana, India | |||
| Lifemediline Care Private Limited | ₹57.13 Lakh (FY 2021) | 21.0% | Jaipur, Rajasthan, India | |||
| Lifesenz Cancer Research Labs Private Limited | ₹57.13 Lakh (FY 2025) | 157.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of X-Med Royal Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving X-Med Royal Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for X-Med Royal Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for X-Med Royal Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
X-Med Royal Pharma Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Mukhtar Hussain was appointed as Director on 08 Oct 2020.
Frequently asked questions
X-Med Royal Pharma is an active private limited company based in Moradabad, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 20 March 2020 (6+ years old) and is registered under CIN U51909UP2020PTC128006.
X-Med Royal Pharma has 4 current directors:
- Mukhtar Hussain - Director
- Miraj Ul Nabi - Director
- Mohammad Fareed - Director
- Qurresh Husain - Director
The latest financial statements of X-Med Royal Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of X-Med Royal Pharma is U51909UP2020PTC128006. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
X-Med Royal Pharma was incorporated on 20 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of X-Med Royal Pharma by revenue are Science House Healthcare Private Limited, Yrs World Trade Corporate Private Limited, Dasam Kirat Dialysis Center Private Limited, Badgu Health Services Private Limited, Anagen Clinics Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Mukhtar Hussain was appointed as Director on 08 Oct 2020. Miraj Ul Nabi was appointed as Director on 20 Mar 2020. Mohammad Fareed was appointed as Director on 20 Mar 2020. X-Med Royal Pharma has 4 board changes on record in total.
Yes, X-Med Royal Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-59-0005266).
The registered office of X-Med Royal Pharma is at 204 – A Lajpat Nagar, Moradabad, Uttar Pradesh, India – 244001.
X-Med Royal Pharma operates in the trading industry, in the specialty segment.
X-Med Royal Pharma can be reached at its registered office: 204 – A Lajpat Nagar, Moradabad, Uttar Pradesh, India – 244001.

